본문

  1. Home
351 Results:PP:ELSEVIER B V 0.190 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
341
Bisphosphonates in Paget's disease
Bisphosphonates in Paget's disease
Reid, I. R., | Elsevier Inc | 2011 ,
342
Bisphosphonates for postmenopausal osteoporosis
Bisphosphonates for postmenopausal osteoporosis
Eastell, R., | Elsevier Inc | 2011 ,
343
The kidney and bisphosphonates
The kidney and bisphosphonates
Miller, P. D., | Elsevier Inc | 2011 ,
344
Bisphosphonates in oncology
Bisphosphonates in oncology
Coleman, R. E., | Elsevier Inc | 2011 ,
345
Bisphosphonates in preclinical bone oncology
Bisphosphonates in preclinical bone oncology
Clezardin, P., | Elsevier Inc | 2011 ,
346
Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know
Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know
Allen, M. R., | Elsevier Inc | 2011 ,
347
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Bellido, T, | Elsevier Inc | 2011 ,
348
Pharmacology of bisphosphonates
Pharmacology of bisphosphonates
Cremers, S., | Elsevier Inc | 2011 ,
349
Biochemical and molecular mechanisms of action of bisphosphonates
Biochemical and molecular mechanisms of action of bisphosphonates
Rogers, M. J., | Elsevier Inc | 2011 ,
350
The relationship between the chemistry and biological activity of the bisphosphonates
The relationship between the chemistry and biological activity of the bisphosphonates
Ebetino, F. H., | Elsevier Inc | 2011 ,
처음이전30313233343536이후마지막